Testing effectiveness (Phase 2)Study completedNCT00665847
What this trial is testing
TMC125-TiDP35-C213: Safety and Antiviral Activity of Etravirine (TMC125) in Treatment-Experienced, HIV Infected Children and Adolescents
Who this might be right for
HIV-1
Tibotec Pharmaceuticals, Ireland 103